Soluble Triggering Receptor Expressed on Myeloid Cells-1 as a marker to differentiate septic from aseptic meningitis in children: comparison with procalcitonin and C-reactive protein

被引:0
|
作者
Hassan, Azza M. [1 ]
Hagar, Hamdy Abo [1 ]
El Saadany, Sherif [1 ]
机构
[1] Tanta Univ, Fac Med, Dept Microbiol & Immunol Pediat & Trop Med, Tanta, Egypt
来源
EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY | 2011年 / 9卷 / 02期
关键词
Soluble Triggering Receptor Expressed on Myeloid Cells-1; Procalcitonin; C-Reactive Protein; Septic meningitis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Differentiating between septic and aseptic meningitis remains a challenge. Procalcitonin (PCT) was suggested by many researchers as a sensitive marker for early diagnosis of septic meningitis but with varying discriminative power. Triggering receptor expressed on myeloid cells-1 (TREM-1), a neutrophil and monocyte receptor, is up-regulated during infection with potential role during sepsis. Objectives: The aim of this study was to evaluate the diagnostic accuracy of soluble TREM-1 in comparison to PCT and C-reactive protein (CRP) in early diagnosis of septic meningitis and its usefulness to distinguish between septic and aseptic meningitis in children. Study design: Fifty-one children aged 2 to 162 months identified as possible cases of meningitis were included in this case control study. Beside Gram staining, cultures of blood and cerebrospinal fluid (CSF) and latex agglutination test of CSF, CRP, serum PCT and soluble TREM-1 (sTREM-1) measurement was done on admission, and after 48-72 hours of treatment. Results: Septic meningitis was diagnosed in 16 (44%) of the studied cases. Although patients with septic meningitis had a significant increase in serum sTREM-1 and PCT levels at the time of admission (median, 25.2 ng/ml and 79.1ng/ml, respectively) in comparison with patients with aseptic meningitis (4.6 ng/ml and 0.7 ng/ml, respectively) and control group (4.1 ng/ml and 0.3 ng/ml, respectively) (p < 0.0001), sTREM-1 showed significantly higher sensitivity (93.7%) and specificity (94.3%) in the early prediction of sepsis with an area under the Receiver Operator Characteristic (ROC) curve (95% CI) of 0.94 (0.84 - 0.99) at a cutoff value of 12.4 ng/ml. Moreover, sTREM-1 but not PCT or CRP concentration was significantly lower (P=0.007) at admission in patients with poor outcome than in those with good prognosis. Conclusions: Both serum PCT and sTREM-1 are valuable in early distinguishing septic from aseptic meningitis in children but with markedly higher diagnostic discriminatory power for sTREM-1. Moreover, sTREM-1 has a significant value in predicting the prognosis of cases with septic meningitis.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 47 条
  • [31] Correlation of Serum-Soluble Triggering Receptor Expressed on Myeloid Cells-1 with Clinical Disease Activity in Inflammatory Bowel Disease
    Park, Jae Jun
    Cheon, Jae Hee
    Kim, Bo Young
    Kim, Duk Hwan
    Kim, Eun Soo
    Kim, Tae Il
    Lee, Kyoung Ryul
    Kim, Won Ho
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (07) : 1525 - 1531
  • [32] Diagnostic value of Serum Procalcitonin Levels in children with meningitis: a comparison with blood leukocyte count and C-reactive protein
    Ibrahim, Khaled Abdulqawi
    Abdel-Wahab, Alsayed Ahmed
    Ibrahim, Ahmed Sayed
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2011, 61 (04) : 346 - 351
  • [33] Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases
    Jung, Yoon Suk
    Park, Jae Jun
    Kim, Seung Won
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (11) : 897 - 903
  • [34] Role of soluble triggering receptor expressed on myeloid cells-1 for diagnosing ventilator-associated pneumonia after cardiac surgery: an observational study
    Matsuno, Alessandra K.
    Carlotti, Ana P. C. P.
    BMC CARDIOVASCULAR DISORDERS, 2013, 13
  • [35] Serum ratio of soluble triggering receptor expressed on myeloid cells-1 to creatinine is a useful marker of infectious complications in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis
    Hirayama, Kouichi
    Nagai, Miho
    Ebihara, Itaru
    Shimohata, Homare
    Kobayashi, Masaki
    Koyama, Akio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (03) : 868 - 874
  • [36] Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection
    Adib-Conquy, Minou
    Monchi, Mehran
    Goulenok, Cyril
    Laurent, Ivan
    Thuong, Marie
    Cavaillon, Jean-Marc
    Adrie, Christophe
    SHOCK, 2007, 28 (04): : 406 - 410
  • [37] Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome
    Edel, Yonatan
    Kliminski, Vitaly
    Pokroy-Shapira, Elisheva
    Oren, Shirly
    Lazar, Ariela Dortort
    Basson, Yael Pri-Paz
    Egbaria, Mohammad
    Molad, Yair
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [38] Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus
    Kim, J.
    Koh, J. K.
    Lee, E. Y.
    Park, J. A.
    Kim, H. A.
    Lee, E. B.
    Garlanda, C.
    Cotena, A.
    Song, Y. W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 773 - 778
  • [39] Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity
    Saurer, Leslie
    Rihs, Silvia
    Birrer, Michele
    Saxer-Seculic, Nikolina
    Radsak, Markus
    Mueller, Christoph
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (09) : 913 - 923
  • [40] Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study
    Kwofie, L.
    Rapoport, B. L.
    Fickl, H.
    Meyer, P. W. A.
    Rheeder, P.
    Hlope, H.
    Anderson, R.
    Tintinger, G. R.
    ANNALS OF HEMATOLOGY, 2012, 91 (04) : 605 - 611